Antibody-Drug Conjugates in Recurrent or Metastatic HNSCC: Relevant Targets, Clinical Development, and Future Prospects - Quiz - MDSpire

Antibody-Drug Conjugates in Recurrent or Metastatic HNSCC: Relevant Targets, Clinical Development, and Future Prospects

  • By

  • Zhao, Hu

  • Zhang, Senxuan

  • Wang, Fang

  • Yu, Peirong

  • Li, Jin

  • Jia, Lina

  • He, Pengfei

  • Liu, Run

  • Zhang, Jian

  • Wang, KeXin

  • Han, Rui

  • Huangfu, Hui

  • May 5, 2026

  • 0 min

Share

Original Source(s)

Antibody-Drug Conjugates in Recurrent or Metastatic HNSCC: Relevant Targets, Clinical Development, and Future Prospects

  • by Zhao, Hu , Zhang, Senxuan , Wang, Fang , Yu, Peirong , Li, Jin , Jia, Lina , He, Pengfei , Liu, Run , Zhang, Jian , Wang, KeXin , Han, Rui , Huangfu, Hui

  • May 5, 2026

Related Content

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer

Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report